Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment. [electronic resource]
Producer: 20180308Description: 398-410 p. digitalISSN:- 1865-3774
- Adult
- Aged
- Aniline Compounds -- administration & dosage
- Asian People
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Cohort Studies
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Drug Tolerance
- Enzyme Inhibitors -- pharmacology
- Female
- Follow-Up Studies
- Humans
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Nitriles -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Quinolines -- administration & dosage
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.